编辑精选——经皮深静脉动脉化治疗无常规血运重建选择的慢性肢体威胁性缺血:系统评价与Meta分析
本系统评价与Meta分析检索四个数据库(2018年1月至2024年6月),纳入10项非随机研究共351例无常规血运重建选择的慢性肢体威胁性缺血(CLTI)患者,评估经皮深静脉动脉化(pDVA)的可行性与临床结局。结果显示6个月和12个月无截肢生存率分别为72.6±2.8%和66.0±3.1%,手术成功率为95.5%(95%CI 92.4-98.7%),证据总体确定性低。
要点
- pDVA在高度专业化中心对无常规血运重建选择的CLTI患者显示出可接受的可行性。
- 6个月和12个月无截肢生存率分别为72.6±2.8%和66.0±3.1%(5项研究,260例患者)。
- 手术成功率为95.5%(95%CI 92.4-98.7%),但证据总体确定性低,临床影响和成本效益需进一步评估。
核心结论
- 本Meta分析表明,在高度专业化机构中,对无常规血运重建选择的CLTI患者行pDVA具有可接受的可行性。
- 时间至事件结局的Meta分析显示,pDVA可提供长达12个月的合理无截肢生存率,但证据总体确定性低。
- 在部分选择的CLTI患者中可考虑更广泛地采用pDVA,但其临床影响和成本效益需进一步评估。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、Embase、Google Scholar和Cochrane数据库,检索时间范围为2018年1月至2024年6月。
- 纳入10项非随机研究,共351例无常规血运重建选择的CLTI患者;平均年龄70.3岁,男性占67.6%。
- 大多数手术使用胫后动脉;对时间至事件结局(均值±标准差)进行Meta分析,主要结局为无截肢生存率,次要结局包括免于截肢、总生存率、手术成功率、通畅率、再干预和完全伤口愈合。
主要发现
- 6个月和12个月无截肢生存率分别为72.6±2.8%和66.0±3.1%(5项研究,260例患者)。
- 6个月和12个月总生存率分别为85.0±2.3%和77.7±2.9%(5项研究,260例患者)。
- 手术成功率为95.5%(95%CI 92.4-98.7%;9项研究,330例患者)。
- 6个月一期和二期通畅率分别为23.4%(95%CI 13.6-33.2%)和54.9%(95%CI 34.3-75.5%;4项研究,241例患者)。
- 12个月再干预率和完全伤口愈合率分别为41.7%(95%CI 25.7-57.7%)和46.0%(95%CI 31.7-60.3%;4项研究190例患者和5项研究190例患者)。
关键数值与推荐
- 无截肢生存率6个月72.6±2.8%、12个月66.0±3.1%(5项研究,260例患者)。
- 总生存率6个月85.0±2.3%、12个月77.7±2.9%(5项研究,260例患者)。
- 手术成功率95.5%(95%CI 92.4-98.7%;9项研究,330例患者)。
- 一期通畅率6个月23.4%(95%CI 13.6-33.2%),二期通畅率6个月54.9%(95%CI 34.3-75.5%;4项研究,241例患者)。
- 再干预率12个月41.7%(95%CI 25.7-57.7%;4项研究,190例患者),完全伤口愈合率12个月46.0%(95%CI 31.7-60.3%;5项研究,190例患者)。
临床怎么用
- 作者认为,在高度专业化机构中,对无常规血运重建选择的CLTI患者行pDVA具有可接受的可行性。
- 作者认为,在部分选择的CLTI患者中可考虑更广泛地采用pDVA。
- 作者指出,pDVA的临床影响和成本效益需进一步评估。
局限性
- 证据总体确定性低。
- pDVA的临床影响和成本效益需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Percutaneous deep venous arterialisation (pDVA) is a state of the art technique for treating patients with chronic limb threatening ischaemia (CLTI) with no conventional option for revascularisation. There are limited large scale data examining the clinical effectiveness of pDVA for patients with end stage CLTI. DATA SOURCES: MEDLINE, Embase, Google Scholar, and Cochrane databases. REVIEW METHODS: Four databases were searched from January 2018 to June 2024 to identify studies investigating the feasibility and clinical outcomes of pDVA for patients with CLTI with no conventional revascularisation options. Meta-analysis of time to event outcomes (mean ± standard deviation) was performed for amputation free survival as the primary outcome, and freedom from amputation and overall survival as secondary outcomes. Other secondary outcomes (mean and 95% confidence interval [CI]) were procedural success rate, patency, re-intervention, and complete wound healing. RESULTS: Ten non-randomised studies were included with 351 patients. The mean patient age was 70.3 years, and 67.6% were male. Most procedures used the posterior tibial artery. The aggregated rate of amputation free survival at six and twelve months (five studies, 260 patients) was 72.6 ± 2.8% and 66.0 ± 3.1%, respectively, while the overall survival at six and twelve months (five studies, 260 patients) was 85.0 ± 2.3% and 77.7 ± 2.9%, respectively. The procedural success rate (nine studies, 330 patients) was 95.5% (95% CI 92.4 - 98.7%). Primary and secondary patency at six months (four studies, 241 patients) was 23.4% (95% CI 13.6 - 33.2%) and 54.9% (95% CI 34.3 - 75.5%), respectively. The rates of re-intervention (four studies, 190 patients) and complete wound healing (five studies, 190 patients) at twelve months were 41.7% (95% CI 25.7 - 57.7%) and 46.0% (95% CI 31.7 - 60.3%), respectively. CONCLUSION: This meta-analysis demonstrated acceptable feasibility for no option CLTI at highly specialised institutions for patients undergoing pDVA. Meta-analysis of time to event outcomes revealed that pDVA provides reasonable amputation free survival for up to twelve months, albeit with a overall low certainty of evidence. Wider adoption of pDVA may be considered in selected patients with CLTI, although its clinical impact and cost effectiveness require further evaluation.
引用
- Tsukagoshi J, Orrukem M, Shimamura J, et al. Editor's Choice - Short and Midterm Outcomes of Percutaneous Deep Venous Arterialisation for No Option Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2024. PMID: 39121906. doi:10.1016/j.ejvs.2024.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。